Status:
UNKNOWN
The Analgesic Effect of Butorphanol After Cesarean Section
Lead Sponsor:
Tongji Hospital
Conditions:
Analgesia
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
We evaluated the clinical effect of Butorphanol on postoperative analgesia by observing the vital signs of patients, general condition of newborns and pain assessment.
Eligibility Criteria
Inclusion
- Healthy women at term (37 to 42 weeks of gestation), who desired cesarean section were eligible to participate. undergoing ；No drug sensitive history
Exclusion
- Patients with a history of anesthetics allergy and patients with preterm labor, multiple pregnancies and severe obstetric complications
Key Trial Info
Start Date :
August 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04490980
Start Date
August 1 2020
End Date
December 31 2020
Last Update
July 29 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.